Nutex Health Inc. (NASDAQ:NUTX) Stock Has Average Price Target of $342.00 According to Brokerages

Shares of Nutex Health Inc. (NASDAQ:NUTX – Get Free Report) have received a consensus rating of “Moderate Buy” from the five brokerages that are covering the firm, MarketBeat reports. Two analysts have rated the stock with a hold recommendation and three have issued a buy recommendation on the company. The average 12 month price target among brokers that have issued ratings on the stock in the last year is $342.00.

Several equities research analysts have issued reports on NUTX shares. Wall Street Zen upgraded shares of Nutex Health from a “hold” rating to a “buy” rating in a research note on Saturday, November 14th. Lake Street Capital lifted their price target on shares of Nutex Health from $310.00 to $333.00 and gave the stock a “buy” rating in a research note on Monday, November 9th. Ladenburg Thalmann & Co. Inc. began coverage on shares of Nutex Health in a report on Monday, October 26th. They issued a “buy” rating and a $336.00 price objective on the stock. Zacks Research cut Nutex Health from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, October 6th. Finally, B. Riley Financial raised their price objective on Nutex Health from $325.00 to $357.00 and gave the company a “buy” rating in a research note on Monday, November 9th.

Get Our Latest Analysis on Nutex Health

Nutex Health Trading Down 6.2%

NUTX opened at $162.10 on Friday. The company has a market cap of $1.11 billion, a P/E ratio of 6.92 and a beta of 0.66. Nutex Health has a one year low of $83.99 and a one year high of $226.16. The business’s 50-day simple moving average is $200.34 and its 200-day simple moving average is $152.42. The company has a debt-to-equity ratio of 0.59, a quick ratio of 4.72 and a current ratio of 4.76.

Nutex Health (NASDAQ:NUTX – Get Free Report) last released its quarterly earnings results on Thursday, November 5th. The company reported $5.71 EPS for the quarter, topping the consensus estimate of $5.54 by $0.17. The business had revenue of $217.61 million during the quarter, compared to analysts’ expectations of $214.82 million. Nutex Health had a return on equity of 34.43% and a net margin of 20.68%. As a group, equities research analysts expect that Nutex Health will post 27.70 EPS for the current fiscal year.

Nutex Health Announces Dividend

The business also recently declared a special dividend, which will be paid on Monday, December 14th. Stockholders of record on Monday, November 30th will be given a dividend of $2.00 per share. The ex-dividend date of this dividend is Monday, November 30th.

Insider Activity at Nutex Health

In other Nutex Health news, Director Scott Saunders sold 203 shares of the business’s stock in a transaction on Friday, September 18th. The shares were sold at an average price of $214.25, for a total transaction of $43,492.75. Following the completion of the sale, the director owned 400 shares in the company, valued at $85,700. The trade was a 33.67% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Insiders own 44.68% of the company’s stock.

Hedge Funds Weigh In On Nutex Health

Large investors have recently bought and sold shares of the business. BlackRock Inc. bought a new position in shares of Nutex Health during the second quarter valued at approximately $69,612,000. Winmill & CO. Inc. bought a new stake in Nutex Health in the second quarter valued at $11,168,000. Empowered Funds LLC bought a new stake in shares of Nutex Health during the second quarter valued at approximately $7,720,000. Bank of New York Mellon Corp acquired a new position in shares of Nutex Health during the second quarter worth approximately $3,956,000. Finally, Bridge City Capital LLC acquired a new position in shares of Nutex Health during the third quarter worth approximately $3,918,000. Institutional investors own 5.32% of the company’s stock.

About Nutex Health

(Get Free Report)

Nutex Health is a Houston-based healthcare company with two main divisions: a Hospital Division and a Management Services Organization (MSO). Its Hospital Division develops and operates micro-hospitals that provide emergency care and other hospital and outpatient services. Through its MSO, Nutex provides administrative, technology, analytics and other management support to affiliated physician-led organizations. These services support care coordination and population health management. Founded by physician Thomas Vo, who serves as the company’s chairman and chief executive officer, Nutex operates in the United States.

See Also

Analyst Recommendations for Nutex Health (NASDAQ:NUTX)

Receive News & Ratings for Nutex Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutex Health and related companies with MarketBeat.com's FREE daily email newsletter.